Elucidata, which makes software to support drug discovery, recently released a metabolomics analysis platform that includes machine learning technology.
Researchers described diet-related patterns of gut microbial diversity, microbiome ties to psychiatric disease, and more.
In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.
The company will provide the services for the VA's Million Veteran Program, which is studying the link between genes and disease in US veteran volunteers.
ReviveMed's technology uses artificial intelligence-based analysis of metabolomics data for drug discovery and development.
The companies will integrate Agilent's Seahorse XFe96/XFe24 Analyzers with BioTek's Cytation 1 Cell Imaging Multi-Mode Reader.
In PNAS this week: genetic diversity of MERS in African camels, centromere evolution in Cryptococcus, and more.
The companies will offer a system for the identification and quantitation of metabolites in biological samples.
In PLOS this week: metabolite profiles of typhoid fever, shifts in cell-free DNA levels following exercise, and more.
The researchers found multiple enzymes that indicate causes of dysregulated adaptive immunity and tissue damage in fatal Ebola virus disease.
The Los Angeles Times reports that a case of the novel coronavirus making people ill in China has been reported in the US.
A bipartisan group of senators has introduced a bill seeking increased funding for certain fields, including synthetic biology, ScienceInsider reports.
Discover magazine writes that paleoproteomics is increasing being used in archaeology, paleoanthropology, and paleontology, including a recent study of a 6,000-year-old ring.
In Nucleic Acids Research this week: mutagenic effects of ultraviolet "A" light, post-transcription effects of synonymous mutations, and more.